To verify the gene expression pattern of lipid metabolism associated targets that also contribute to NAFLD regulation, ADIPOQ, PPARG, IGF1, PPARA, MTHFR, SERPINE1, NR1H4, and APOA2 mRNA levels were tested. This evidence concerns the gene APOA2 and metabolic dysfunction-associated steatotic liver disease.